264 related articles for article (PubMed ID: 7960987)
21. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization.
Naida JD; Davis MA; Lawrence TS
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):675-80. PubMed ID: 9635719
[TBL] [Abstract][Full Text] [Related]
22. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
[TBL] [Abstract][Full Text] [Related]
23. BrdUrd-induced radiosensitization of two human tumour cell lines at iso-levels of incorporation.
Franken NA; Van Bree C; Kipp JB; Rodermond HM; Haveman J; Barendsen GW
Oncol Rep; 2000; 7(5):937-40. PubMed ID: 10948317
[TBL] [Abstract][Full Text] [Related]
24. Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitization.
Lawrence TS; Burke R; Davis MA
Radiat Res; 2000 Aug; 154(2):140-4. PubMed ID: 10931684
[TBL] [Abstract][Full Text] [Related]
25. Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells.
Pestalozzi BC; McGinn CJ; Kinsella TJ; Drake JC; Glennon MC; Allegra CJ; Johnston PG
Br J Cancer; 1995 Jun; 71(6):1151-7. PubMed ID: 7779704
[TBL] [Abstract][Full Text] [Related]
26. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
[TBL] [Abstract][Full Text] [Related]
27. Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.
McLaughlin PW; Lawrence TS; Seabury H; Nguyen N; Stetson PL; Greenberg HS; Mancini WR
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):601-7. PubMed ID: 7928491
[TBL] [Abstract][Full Text] [Related]
28. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells.
Tang HY; Weber KL; Lawrence TS; Merchant AK; Maybaum J
Cancer Chemother Pharmacol; 1996; 37(5):486-90. PubMed ID: 8599873
[TBL] [Abstract][Full Text] [Related]
29. The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
Lawrence TS; Heimburger DK; Shewach DS
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):377-81. PubMed ID: 1991704
[TBL] [Abstract][Full Text] [Related]
30. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity.
Canman CE; Tang HY; Normolle DP; Lawrence TS; Maybaum J
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10474-8. PubMed ID: 1438236
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
Ren Q; Kao V; Grem JL
Clin Cancer Res; 1998 Nov; 4(11):2811-8. PubMed ID: 9829747
[TBL] [Abstract][Full Text] [Related]
32. Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells.
Yoshida M; Hosoi Y; Miyachi H; Ishii N; Matsumoto Y; Enomoto A; Nakagawa K; Yamada S; Suzuki N; Ono T
Int J Radiat Biol; 2002 Jun; 78(6):503-12. PubMed ID: 12065055
[TBL] [Abstract][Full Text] [Related]
33. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
[TBL] [Abstract][Full Text] [Related]
34. Genetic variation in thymidylate synthase confers resistance to 5-fluorodeoxyuridine.
Hughey CT; Barbour KW; Berger FG; Berger SH
Adv Exp Med Biol; 1993; 339():67-76. PubMed ID: 8178730
[TBL] [Abstract][Full Text] [Related]
35. Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects.
Lawrence TS; Davis MA; Maybaum J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):519-23. PubMed ID: 8005809
[TBL] [Abstract][Full Text] [Related]
36. In vitro studies of Taxol as a radiation sensitizer in human tumor cells.
Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
J Natl Cancer Inst; 1994 Mar; 86(6):441-6. PubMed ID: 7907149
[TBL] [Abstract][Full Text] [Related]
37. Radiosensitization of tumour cells by cantharidin and some analogues.
Price WA; Stobbe CC; Park SJ; Chapman JD
Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.
Latz D; Fleckenstein K; Eble M; Blatter J; Wannenmacher M; Weber KJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):875-82. PubMed ID: 9652852
[TBL] [Abstract][Full Text] [Related]
39. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
[TBL] [Abstract][Full Text] [Related]
40. Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation.
Lawrence TS; Davis MA; Loney TL
Cancer Res; 1996 Jul; 56(14):3203-6. PubMed ID: 8764107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
